What is required for all chemotherapy, PCA, and Heparin drips?

The requirement for verification by two registered nurses (RNs) documented in the electronic Medication Administration Record (eMAR) for chemotherapy, patient-controlled analgesia (PCA), and heparin drips is based on safety and risk management practices in healthcare.

Chemotherapy agents and high-risk medication therapies like PCA and heparin can have serious consequences if administered incorrectly, making it essential to have multiple checks in place to prevent errors. The second RN's verification serves as a safeguard, ensuring that the drug, dosage, and rate of administration are accurate and appropriate for the patient. This process helps to minimize the risks of adverse reactions and enhances the overall quality of patient care.

This practice not only aligns with safety protocols but also fosters a culture of accountability among healthcare professionals. Proper documentation in the eMAR signifies that the verification process was completed correctly and reinforces the system of checks and balances designed to protect patients.

While other elements, such as documentation in the patient chart and consultations with prescribing physicians, are also vital in patient care management, they do not specifically address the critical need for dual verification of high-risk therapies.